High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: a population-based analysis
Keyword(s):
Keyword(s):
2019 ◽
Vol Volume 11
◽
pp. 1289-1297
◽
2019 ◽
Vol 36
(12)
◽
pp. 3446-3457
◽
Keyword(s):
2010 ◽
Vol 28
(18)
◽
pp. e299-e300
◽
2012 ◽
Vol 13
(9)
◽
pp. 927-935
◽
2014 ◽
Vol 12
(4)
◽
pp. e127-e131
◽
Keyword(s):
Keyword(s):
Keyword(s):